Atlas Trials

To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c

Clinical trial NCT00294723 · TERMINATED

Trial details

NCT number
NCT00294723
Sponsor
Novo Nordisk A/S
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2006-02-01
Primary completion
2008-11-01
Enrollment
746

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.